Shane Deegan completed his Ph.D at NUI Galway in 2012, achieving 8 publications from his research focusing on the identification of alternative cell death pathways in cancer cells. Shane was recruited by an international diagnostic company as a senior scientist in their R&D department.

His research focused on biomarker discovery and multiplex immunoassay development. His experience in generating SOP’s, employing quality control systems and adhering to GMP and GLP guidelines was developed while working there.

Shane was the first recruit to Aquila Bioscience in 2014. Shane’s role in Aquila includes; managing R&D activities, market research, networking, grant/contract writing, implementing quality systems and administrative roles.